Vaccine Therapy in Combination With Ampligen® and/or Sargramostim in Patients With Stage II-IV HER2-Positive Breast Cancer

This study is currently recruiting participants.

Study NCT01355393 Information provided by Fred Hutchinson Cancer Research Center

First Received: May 16, 2011 Last Updated: January 3, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	January 2013 (Final data collection date for primary outcome measure)